[go: up one dir, main page]

NO20000748L - Pyrazolo(3,4-D)pyrimidiner med antikonvulsiv og antiallergisk/antiastmatisk virkning - Google Patents

Pyrazolo(3,4-D)pyrimidiner med antikonvulsiv og antiallergisk/antiastmatisk virkning

Info

Publication number
NO20000748L
NO20000748L NO20000748A NO20000748A NO20000748L NO 20000748 L NO20000748 L NO 20000748L NO 20000748 A NO20000748 A NO 20000748A NO 20000748 A NO20000748 A NO 20000748A NO 20000748 L NO20000748 L NO 20000748L
Authority
NO
Norway
Prior art keywords
pyrazolo
anticonvulsant
antiallergic
pyrimidines
antiasthmatic action
Prior art date
Application number
NO20000748A
Other languages
English (en)
Other versions
NO20000748D0 (no
NO314760B1 (no
Inventor
Thomas Arnold
Hans-Joachim Lankau
Manfred Menzer
Angelika Rostock
Christine Tober
Klaus Unverferth
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of NO20000748D0 publication Critical patent/NO20000748D0/no
Publication of NO20000748L publication Critical patent/NO20000748L/no
Publication of NO314760B1 publication Critical patent/NO314760B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000748A 1998-06-22 2000-02-15 Pyrazolo(3,4-d)pyrimidiner, fremgangsmåte for fremstilling, farmasöytiske sammensetninger inneholdende disse, samt anvendelse av pyrimidinene NO314760B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19827679A DE19827679A1 (de) 1998-06-22 1998-06-22 Adenosinrezeptoraffine, antikonvulsiv und antiallergisch/antiasthmatisch wirkende Pyrazolo[3,4-d]pyrimidine und Verfahren zu deren Herstellung
PCT/EP1999/003863 WO1999067243A1 (de) 1998-06-22 1999-06-04 Antikonvulsiv und antiallergisch/antiasthmatisch wirkende pyrazolo(3,4-d)pyrimidine
CZ2000594A CZ288195B6 (en) 1998-06-22 1999-06-04 Derivative of pyrazolo[3,4-d]pyrimidines exhibiting anticonvulsive a antiallergic/anti-asthmatic activity, process of its preparation and use
CA002297706A CA2297706A1 (en) 1998-06-22 2000-02-02 Anticonvulsive and antiallergic/anti-asthmatic pyrazolo-(3,4-d)pyrimidines having affinity for the adenosine receptor, and process for their preparation

Publications (3)

Publication Number Publication Date
NO20000748D0 NO20000748D0 (no) 2000-02-15
NO20000748L true NO20000748L (no) 2000-04-07
NO314760B1 NO314760B1 (no) 2003-05-19

Family

ID=27171156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000748A NO314760B1 (no) 1998-06-22 2000-02-15 Pyrazolo(3,4-d)pyrimidiner, fremgangsmåte for fremstilling, farmasöytiske sammensetninger inneholdende disse, samt anvendelse av pyrimidinene

Country Status (26)

Country Link
US (1) US6054460A (no)
EP (1) EP1005471B1 (no)
JP (1) JP2002518499A (no)
CN (1) CN1126753C (no)
AT (1) ATE223412T1 (no)
AU (1) AU748090B2 (no)
BG (1) BG104150A (no)
BR (1) BR9906552A (no)
CA (2) CA2301107A1 (no)
CZ (1) CZ288195B6 (no)
DE (2) DE19827679A1 (no)
DK (1) DK1005471T3 (no)
EA (1) EA002768B1 (no)
ES (1) ES2182541T3 (no)
HU (1) HUP0003783A3 (no)
IL (1) IL134439A0 (no)
NO (1) NO314760B1 (no)
NZ (1) NZ502880A (no)
PL (1) PL338897A1 (no)
PT (1) PT1005471E (no)
RU (1) RU2194050C2 (no)
SK (1) SK283506B6 (no)
TR (1) TR200000473T1 (no)
TW (1) TW449476B (no)
WO (1) WO1999067243A1 (no)
ZA (1) ZA200000742B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042092A1 (de) * 2000-08-26 2002-03-07 Dresden Arzneimittel Antikonvulsiv wirkende 2,5-Dihydro-pyrazolo(3,4-d)pyrimidin-4-one und Verfahren zu deren Darstellung
WO2012125400A1 (en) * 2011-03-14 2012-09-20 Acorn Biomedical, Inc. Compositions and methods using adenosine a3 receptor antagonists for the treatment of inflammatory eye diseases
CN106749271B (zh) * 2016-12-07 2019-04-05 青岛科技大学 一类[1,2,4]-三氮唑并[1,5-a]嘧啶酮类杂环化合物、其制备方法及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
DE3712735A1 (de) * 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
DE19649460A1 (de) * 1996-11-26 1998-05-28 Bayer Ag Neue substituierte Pyrazolderivate

Also Published As

Publication number Publication date
DE59902538D1 (de) 2002-10-10
AU4605499A (en) 2000-01-10
PT1005471E (pt) 2003-01-31
EA002768B1 (ru) 2002-08-29
EA200000249A1 (ru) 2000-08-28
DK1005471T3 (da) 2002-10-14
SK283506B6 (sk) 2003-08-05
IL134439A0 (en) 2001-04-30
ES2182541T3 (es) 2003-03-01
TW449476B (en) 2001-08-11
AU748090B2 (en) 2002-05-30
CN1126753C (zh) 2003-11-05
SK2252000A3 (en) 2000-08-14
BG104150A (en) 2000-12-29
EP1005471A1 (de) 2000-06-07
CZ2000594A3 (cs) 2000-10-11
BR9906552A (pt) 2000-08-15
NZ502880A (en) 2001-12-21
DE19827679A1 (de) 1999-12-23
NO20000748D0 (no) 2000-02-15
ZA200000742B (en) 2000-10-27
CZ288195B6 (en) 2001-05-16
RU2194050C2 (ru) 2002-12-10
HUP0003783A2 (hu) 2001-04-28
US6054460A (en) 2000-04-25
NO314760B1 (no) 2003-05-19
CN1275128A (zh) 2000-11-29
TR200000473T1 (tr) 2000-09-21
JP2002518499A (ja) 2002-06-25
CA2297706A1 (en) 2001-08-02
EP1005471B1 (de) 2002-09-04
HUP0003783A3 (en) 2001-08-28
WO1999067243A1 (de) 1999-12-29
PL338897A1 (en) 2000-11-20
CA2301107A1 (en) 1999-12-29
ATE223412T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
PL377239A1 (pl) Nowe amino-podstawione pochodne dihydropirymido [4,5-d]-pirymidynonu, ich wytwarzanie i zastosowanie jako środków framaceutycznych
DE69633860D1 (en) Oral aktive adenosinkinase-inhibitoren
DK0793498T3 (da) Bicykliske heterocykliske forbindelser til behandling af impotens
IS5198A (is) Ný efnasambönd
NO307833B1 (no) Pyrimido[5,4-d]pyrimidiner, fysiologisk aksepterbare salter, legemidler inneholdende disse forbindelser og deres anvendelse
CA2269815A1 (en) Thienopyrimidines having pde v-inhibiting action
ATE377592T1 (de) Neurotropische substituierte pyrimidine
BR9609011A (pt) Composto
WO2001066534A3 (en) Cyclic and bicyclic diamino histamine-3 receptor antagonists
NO984081L (no) Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav
HUP0500332A3 (en) Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)-one derivatives, their use and pharmaceutical compositions containing them
BR9815409A (pt) Tienopirimidinas
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
AU2003288869A1 (en) PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
WO2003031447A3 (de) Pyrimidinderivate mit pde-v hemmender wirkung
EE200100388A (et) Püridasino [4,5-b] indool-1-atseetamiidi derivaatide kasutamine ravimite valmistamiseks perifeersete bensodiasepiiniretseptorite düsfunktsioneerimisega seotud haiguste raviks
WO2006033795A3 (en) Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
NO20000748D0 (no) Pyrazolo(3,4-D)pyrimidiner med antikonvulsiv og antiallergisk/antiastmatisk virkning
HK1040512A1 (zh) 具有防驚厥作用的吡唑[3,4-d][1,2,3]三嗪及其生產方法
BR0113517A (pt) 2,5-dihidro-pirazolo[3,4-d] pirimidin-4-onas de efeito anticonvulsivo e processos para preparação dos mesmos
IT1298164B1 (it) Impiego di allantoina come unico principio attivo antivirale per il trattamento e la profilassi dell'herpes simplex
IL203601A (en) 6-Hello-7-History (optionally converted amino) -Pyrazolo [15, - a] pyrimidine and its use in drug preparation
PT1315729E (pt) Compostos na forma de pró-fármacos homodiméricos ou heterodiméricos; processo para a obtenção destes pró-fármacos e seus sais farmacêuticos aceitáveis e utilização dos compostos no tratamento de doenças ou disfunções mediadas por fosfodiesterases

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees